Revenio Group Corporation: INCREASED NUMBER OF SHARES ENTERED INTO TRADE REGISTER

Revenio Group Corporation Stock Exchange Release 14 November 2014 at 09:00 hrs

INCREASED NUMBER OF SHARES ENTERED INTO TRADE REGISTER

38,459 new share subscriptions based on the company's 2007B stock options
approved by the Board of Directors of Revenio Group Corporation on 5 November
2014, have been entered into the trade register today. The share subscription
price under 2007B option rights was 1.75 euros per share. The subscription
period for 2007B options was from 1 November 2010 to 1 November 2014.

After these subscriptions, the number of Revenio Group Corporation's shares and
votes will rise to 7,932,078. These increases were recorded in their entirety in
the unrestricted shareholders' equity fund.

Revenio Group Corporation has applied for the listing of its new shares on the
NASDAQ OMX Helsinki in the same series as the company's existing shares.
According to the current estimate, the new shares will be listed on 17 November
2014.



Revenio Group Corporation

Olli-Pekka Salovaara

President and CEO



For further information, please contact:

Olli-Pekka Salovaara, President & CEO, +358 40 567 5520

olli-pekka.salovaara@revenio.fi

www.revenio.fi/



DISTRIBUTION:

NASDAQ OMX Helsinki

Financial Supervisory Authority (FIN-FSA)

Principal media

www.revenio.fi



The Revenio Group in brief

Revenio is a Finnish health tech group whose core business is tonometers. The
Revenio Health Tech segment comprises the business operations of Icare Finland
Oy and Oscare Medical Oy. The widely patented Icare product family is the
current cornerstone of the Group's success. Revenio seeks vigorous growth in
health technology, both organically and through acquisitions and mergers.

The Revenio Group also includes other business operations, which are grouped
under the Technology and Services segment. This segment's operations have a
shared global market and represent the cutting edge of technology products and
services in their industry.

In 2013, the Revenio Group's net sales totaled EUR 25.7 million, with its
operating margin standing at 21.7%. The Revenio Group Corporation is listed on
NASDAQ OMX Helsinki.


[HUG#1871380]